Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026

Go back to Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
(NASDAQ: MIRM) Delayed: 107.77 +0.64 (0.60%)
Previous Close $107.13    52 Week High
Open $108.85    52 Week Low
Day High $109.67    P/E N/A 
Day Low $106.69    EPS
Volume 1,207,238